BioSpace News Archive

Press Releases

InMed Reports First Quarter Fiscal 2027 Financial Results and Provides Corporate Update

November 3, 2026
·
1 min read
Psychedelics

Compass to submit psilocybin depression drug for approval imminently after stock wobbles

Compass Pathways revealed that an FDA filing for COMP360 will be complete “in the next two weeks,” with an expected drug launch in the first half of next year. The update follows a reported regulatory submission for Usona Institute’s own psilocybin candidate for depression on Monday.

November 3, 2026
·
2 min read
·
Heather McKenzie
Press Releases

Neural Therapeutics Provides Corporate Update

November 3, 2026
·
1 min read
Press Releases

Gaelic and Athlone Laboratories Launched Dual-Source Supply Services at CPHI Milan with Comms Strategy Masterminded by 5-Star Google Rated Impact Shine Communications

November 3, 2026
·
3 min read
Earnings

Pfizer, fresh to China’s obesity market, looks to Viagra model to compete

Pfizer is calling upon lessons learned from one of the first drugs ever made available on the internet—Viagra—as it commercializes a new obesity drug in China.

November 3, 2026
·
3 min read
·
Annalee Armstrong